Aprinoia Therapeutics (Aprinoia Therapeutics) Median PS Value : $0.00 (As of Apr. 25, 2024)

View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Aprinoia Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.329. Aprinoia Therapeutics's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is $0.00.

As of today (2024-04-25), Aprinoia Therapeutics's share price is $0.00. Aprinoia Therapeutics's Median PS Value is $0.00. Therefore, Aprinoia Therapeutics's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Aprinoia Therapeutics's Median PS Value or its related term are showing as below:

APRI's Price-to-Median-PS-Value is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.66
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Aprinoia Therapeutics Median PS Value Historical Data

The historical data trend for Aprinoia Therapeutics's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Median PS Value Chart

Aprinoia Therapeutics Annual Data

Trend

Dec21

Dec22

Median PS Value

Aprinoia Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23
Median PS Value	-	-	-	-

Competitive Comparison of Aprinoia Therapeutics's Median PS Value

For the Biotechnology subindustry, Aprinoia Therapeutics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Price-to-Median-PS-Value falls into.

Aprinoia Therapeutics Median PS Value Calculation

Aprinoia Therapeutics's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	0.329	*	0
	=	0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aprinoia Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.329.

Aprinoia Therapeutics (NAS:APRI) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Aprinoia Therapeutics's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	0.00	/	0.00
	=

Aprinoia Therapeutics Median PS Value Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines